Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers
Josephine R. Giles(Parker Institute for Cancer Immunotherapy), E. John Wherry(Parker Institute for Cancer Immunotherapy), Nan‐ping Weng(National Institute on Aging), Carl H. June(University of Pennsylvania), Ravi K. Amaravadi(University of Pennsylvania), Tara C. Mitchell(Hospital of the University of Pennsylvania), Lynn M. Schuchter(Eastern Cooperative Oncology Group), Sangeeth M. George(Translational Therapeutics (United States)), Giorgos C. Karakousis(Hospital of the University of Pennsylvania), Junwei Shi(University of Pennsylvania), Derek A. Oldridge(California University of Pennsylvania), Mary Carberry(University of Pennsylvania), Regina M. Young(University of Pennsylvania), Amy E. Baxter(Translational Therapeutics (United States)), Alexander C. Huang(University of Pennsylvania), Lakshmi Chilukuri(Translational Therapeutics (United States)), Hua Huang(Shaoxing University), Sasikanth Manne(Translational Therapeutics (United States)), Zeyu Chen(Kingmed Diagnostics), Lydia Giles(University of Pennsylvania), Xiaowei Xu(University of Pennsylvania), Elizabeth Freilich(University of Pennsylvania)
Cited by 122
Related Papers
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
|Nature|2010|1.8k
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Autophagy in major human diseases
|The EMBO Journal|2021|1.6k
Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma
|Journal of Clinical Investigation|2007|1.1k
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940